Sequoia Genetics, a member of the Saint Petersburg, Russia-based Alkor Bio group of companies, said this week that it has launched a project to develop infrastructure for analyzing genomic information in personalized medicine studies.
The company said a team of bioinformaticians from several undisclosed universities in Saint Petersburg will develop proprietary algorithms for analyzing data and that EMC will provide cloud computing solutions and big data analytics that will be used to process the genomic data.
Sequoia said the project will develop a scalable cloud-based infrastructure that will include customized modules for data compression, transfer, and storage; support integration with most sequencing platforms; and provide an annotated database of clinically significant mutations.
The platform will also include algorithms for genome alignment, assembly, and mutation detection; a database of genetic disorders including current scientific data, recommendations, and reference documents; and it will be integrated with electronic patient record systems.
The project is being supported by the Skolkovo Innovation Center, which supports projects in biomedicine, energy consumption, and nuclear technologies among other areas.
Earlier this year the Skolkovo Fund of Development and Commercialization of New Technologies signed an agreement with EMC to create a center of excellence focused on cloud computing and analytics in the fields of bioinformatics and energy efficiency.
EMC already has a center of excellence based in Saint Petersburg that it said will be "tightly coupled" with the Skolkovo center.